246 related articles for article (PubMed ID: 15659348)
1. GATA1 in normal and malignant hematopoiesis.
Crispino JD
Semin Cell Dev Biol; 2005 Feb; 16(1):137-47. PubMed ID: 15659348
[TBL] [Abstract][Full Text] [Related]
2. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.
Wechsler J; Greene M; McDevitt MA; Anastasi J; Karp JE; Le Beau MM; Crispino JD
Nat Genet; 2002 Sep; 32(1):148-52. PubMed ID: 12172547
[TBL] [Abstract][Full Text] [Related]
3. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
[TBL] [Abstract][Full Text] [Related]
4. Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
Gurbuxani S; Vyas P; Crispino JD
Blood; 2004 Jan; 103(2):399-406. PubMed ID: 14512321
[TBL] [Abstract][Full Text] [Related]
5. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia.
Crispino JD
Pediatr Blood Cancer; 2005 Jan; 44(1):40-4. PubMed ID: 15390312
[TBL] [Abstract][Full Text] [Related]
6. GATA transcription factors in hematologic disease.
Cantor AB
Int J Hematol; 2005 Jun; 81(5):378-84. PubMed ID: 16158817
[TBL] [Abstract][Full Text] [Related]
7. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.
Li Z; Godinho FJ; Klusmann JH; Garriga-Canut M; Yu C; Orkin SH
Nat Genet; 2005 Jun; 37(6):613-9. PubMed ID: 15895080
[TBL] [Abstract][Full Text] [Related]
8. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
Hitzler JK; Cheung J; Li Y; Scherer SW; Zipursky A
Blood; 2003 Jun; 101(11):4301-4. PubMed ID: 12586620
[TBL] [Abstract][Full Text] [Related]
9. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.
Xu G; Nagano M; Kanezaki R; Toki T; Hayashi Y; Taketani T; Taki T; Mitui T; Koike K; Kato K; Imaizumi M; Sekine I; Ikeda Y; Hanada R; Sako M; Kudo K; Kojima S; Ohneda O; Yamamoto M; Ito E
Blood; 2003 Oct; 102(8):2960-8. PubMed ID: 12816863
[TBL] [Abstract][Full Text] [Related]
10. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
[TBL] [Abstract][Full Text] [Related]
11. Natural history of GATA1 mutations in Down syndrome.
Ahmed M; Sternberg A; Hall G; Thomas A; Smith O; O'Marcaigh A; Wynn R; Stevens R; Addison M; King D; Stewart B; Gibson B; Roberts I; Vyas P
Blood; 2004 Apr; 103(7):2480-9. PubMed ID: 14656875
[TBL] [Abstract][Full Text] [Related]
12. Gene expression regulation and domain function of hematopoietic GATA factors.
Shimizu R; Yamamoto M
Semin Cell Dev Biol; 2005 Feb; 16(1):129-36. PubMed ID: 15659347
[TBL] [Abstract][Full Text] [Related]
13. A leukemogenic twist for GATA1.
Look AT
Nat Genet; 2002 Sep; 32(1):83-4. PubMed ID: 12172549
[No Abstract] [Full Text] [Related]
14. [Mutations of erythroid/megakaryocytic transcription factor GATA-1 and leukemia in childhood].
Ito E
Rinsho Ketsueki; 2004 Feb; 45(2):108-14. PubMed ID: 15045818
[No Abstract] [Full Text] [Related]
15. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW
J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366
[TBL] [Abstract][Full Text] [Related]
16. Inherited thrombocytopenia due to GATA-1 mutations.
Millikan PD; Balamohan SM; Raskind WH; Kacena MA
Semin Thromb Hemost; 2011 Sep; 37(6):682-9. PubMed ID: 22102271
[TBL] [Abstract][Full Text] [Related]
17. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
Del Vecchio GC; Giordani L; De Santis A; De Mattia D
Acta Haematol; 2005; 114(2):113-6. PubMed ID: 16103636
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor GATA-1 and Down syndrome leukemogenesis.
Muntean AG; Ge Y; Taub JW; Crispino JD
Leuk Lymphoma; 2006 Jun; 47(6):986-97. PubMed ID: 16840187
[TBL] [Abstract][Full Text] [Related]
19. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
20. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1.
Nichols KE; Crispino JD; Poncz M; White JG; Orkin SH; Maris JM; Weiss MJ
Nat Genet; 2000 Mar; 24(3):266-70. PubMed ID: 10700180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]